Cardiology

The Biology of Heart and Hearing Loss

At a Glance

Sensorineural hearing loss with dilated cardiomyopathy can have several genetic causes affecting energy production or structural proteins in the heart and inner ear. ECGs, echocardiograms, audiograms, and genetic testing help define the condition and distinguish it from JLNS.

While it might seem that your heart and ears have little in common, they share a critical biological requirement: they are organs with high demands for energy and structural integrity. Both the myocardium (heart muscle) and the cochlea (the hearing organ in the inner ear) require a massive, constant supply of energy to function ^[1]. When these systems are disrupted, these two systems are often among the first to show signs of strain ^[2]^[3].

The Biological Connection

The inner ear uses a specialized structure called the stria vascularis to maintain the delicate chemical balance needed for hearing ^[2]. Similarly, the heart muscle must contract and relax billions of times over a lifetime. Both rely on complex cellular mechanisms, including mitochondria (the energy producers of your cells) and structural proteins ^[4].

If these mechanisms fail, the heart muscle can stretch and weaken (dilated cardiomyopathy), and the sensory hair cells in the ear can stop sending clear signals to the brain ^[3]^[5].

Understanding the Genetic Mechanisms

Because several different genetic issues can cause similar symptoms, doctors use clinical examinations (like ECGs, echocardiograms, and audiograms) to guide care immediately, and they may use genetic testing to help identify the exact cause. Diagnosing the heart and hearing findings happens first; identifying the genetic cause is a separate step that may sometimes return a negative result or a “variant of uncertain significance.” Some distinct mechanisms include:

EYA4 Variants (Autosomal Dominant): This gene acts like a regulatory switch for development. Variants can lead to haploinsufficiency, where the body doesn’t have enough of the protein to maintain the heart and ear structures ^[6]. Because it is dominant, it can be passed from a single parent who has the condition ^[7].
Alström Syndrome (ALMS1, Recessive): This involves the ALMS1 gene, which helps manage the function of cells. It is autosomal recessive, meaning a child must inherit a variant from both parents ^[8]. This condition is complex and often includes other symptoms like vision loss, obesity, or diabetes ^[9]^[10].
Mitochondrial Variants (e.g., m.3243A>G): The m.3243A>G variant is a change in the mitochondrial DNA itself. It is passed down from the mother and can cause a wide range of symptoms, including diabetes and stroke-like episodes ^[11]^[12].
Nuclear Mitochondrial Genes (e.g., DNAJC19): This is a rare nuclear gene (inherited recessively) that disrupts how proteins move within the mitochondria, often leading to heart issues and metabolic signs early in childhood ^[13].

Distinguishing “Look-Alikes”

One of the most important tasks for your medical team is making a differential diagnosis—ruling out conditions that look similar but require different treatments. QT measurement, ECGs, and clinical evaluations guide this care immediately.

A common “look-alike” is Jervell and Lange-Nielsen Syndrome (JLNS). Like your condition, JLNS involves both deafness and the heart, but the underlying biology is different:

Feature	Cardio-Auditory Phenotype (EYA4/Alström/Mito)	Jervell and Lange-Nielsen (JLNS)
Primary Heart Issue	Dilated Cardiomyopathy: The heart muscle is physically weak and enlarged ^[7]^[14].	QT Prolongation: Primarily an electrical disorder. The heart structure is usually normal, but its electrical “recharging” time is too long ^[15].
Hearing Loss	Often progressive; may start later in life ^[16].	Usually present at birth (congenital) and profound ^[15].
Inheritance	Varies (Dominant, Recessive, or Maternal) ^[6]^[11].	Always Recessive (requires two mutated genes) ^[15].

Because the treatments for a “weak pump” (dilated cardiomyopathy) and an “electrical delay” (JLNS) are entirely different, identifying the clinical problem through exams and ruling out look-alikes is the most vital step in your care ^[17]^[18].

Common questions in this guide

What connects sensorineural hearing loss with dilated cardiomyopathy?

The inner ear and heart muscle both need a continuous supply of energy and depend on specialized cellular structures. Genetic changes affecting mitochondria or structural proteins can therefore impair hearing and weaken or enlarge the heart muscle.

Which genetic conditions can cause hearing loss and a weak heart?

Examples discussed include EYA4-related disease, Alström syndrome caused by ALMS1 variants, mitochondrial variants such as m.3243A>G, and recessive DNAJC19-related disease. Their inheritance patterns differ: some are dominant, some recessive, and mitochondrial variants are passed through the mother.

How do doctors distinguish this condition from Jervell and Lange-Nielsen syndrome?

An ECG and QT-interval measurement help determine whether the main heart problem is a weakened, enlarged heart muscle or an electrical delay. Jervell and Lange-Nielsen syndrome usually causes congenital profound deafness with QT prolongation, while the hearing loss in this cardio-auditory pattern may develop later.

What tests are used when hearing loss occurs with cardiomyopathy?

Doctors may use an ECG to assess the heart’s electrical activity, an echocardiogram to evaluate its structure and pumping function, and an audiogram to measure hearing. Genetic testing may then help identify the cause, but it is a separate step and can be negative or inconclusive.

What does a negative or uncertain genetic test mean?

A negative test or a variant of uncertain significance may not identify the genetic cause of the heart and hearing findings. Doctors can still evaluate and manage the clinical condition using the examination, ECG, echocardiogram, audiogram, and family history.

Can hearing loss with dilated cardiomyopathy run in families?

Yes, the likelihood and inheritance pattern depend on the underlying cause. EYA4-related disease may be dominant, ALMS1 and DNAJC19-related conditions are recessive, and mitochondrial variants such as m.3243A>G are inherited through the maternal line.

Get notified when new evidence is published on Sensorineural deafness with dilated cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (18)

1
A retrospective cohort study exploring the association between different mitochondrial diseases and hearing loss.
van Kempen CMA, Beynon AJ, Smits JJ, Janssen MCH
Molecular genetics and metabolism 2022; (135(4)):333-341 doi:10.1016/j.ymgme.2022.02.003.
PMID: 35190254
2
Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss.
Tan WJT, Song L
Hearing research 2023; (434()):108783 doi:10.1016/j.heares.2023.108783.
PMID: 37167889
3
Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure.
Wu SP, Kao CY, Wang L, et al.
Nature communications 2015; (6()):8245 doi:10.1038/ncomms9245.
PMID: 26356605
4
Effect of downregulated citrate synthase on oxidative phosphorylation signaling pathway in HEI-OC1 cells.
Xu X, Liu Y, Luan J, et al.
Proteome science 2022; (20(1)):14 doi:10.1186/s12953-022-00196-0.
PMID: 36071491
5
Disruption of Hars2 in Cochlear Hair Cells Causes Progressive Mitochondrial Dysfunction and Hearing Loss in Mice.
Xu P, Wang L, Peng H, et al.
Frontiers in cellular neuroscience 2021; (15()):804345 doi:10.3389/fncel.2021.804345.
PMID: 34975414
6
Insights into the pathophysiology of DFNA10 hearing loss associated with novel EYA4 variants.
Morín M, Borreguero L, Booth KT, et al.
Scientific reports 2020; (10(1)):6213 doi:10.1038/s41598-020-63256-5.
PMID: 32277154
7
Eya4 Induces Hypertrophy via Regulation of p27kip1.
Williams T, Hundertmark M, Nordbeck P, et al.
Circulation. Cardiovascular genetics 2015; (8(6)):752-64 doi:10.1161/CIRCGENETICS.115.001134.
PMID: 26499333
8
A novel variant in ALMS1 in a patient with Alström syndrome and prenatal diagnosis for the fetus in the family: A case report and literature review.
Zhou C, Xiao Y, Xie H, et al.
Molecular medicine reports 2020; (22(4)):3271-3276 doi:10.3892/mmr.2020.11398.
PMID: 32945434
9
Auditory and otologic profile of Alström syndrome: Comprehensive single center data on 38 patients.
Lindsey S, Brewer C, Stakhovskaya O, et al.
American journal of medical genetics. Part A 2017; (173(8)):2210-2218 doi:10.1002/ajmg.a.38316.
PMID: 28573831
10
Characterisation of infantile cardiomyopathy in Alström syndrome using ALMS1 knockout induced pluripotent stem cell derived cardiomyocyte model.
Patel L, Roy A, Barlow J, et al.
Molecular genetics and metabolism 2024; (143(1-2)):108575 doi:10.1016/j.ymgme.2024.108575.
PMID: 39243575
11
The heart in m.3243A>G carriers.
Finsterer J, Zarrouk-Mahjoub S
Herz 2020; (45(4)):356-361 doi:10.1007/s00059-018-4739-6.
PMID: 30128910
12
A case with short stature and proteinuria: atypical presentation of a family with m.3243A>G mutation.
Büyükyılmaz G, İnözü M, Çavdarlı B
The Turkish journal of pediatrics 2024; (66(4)):490-498 doi:10.24953/turkjpediatr.2024.4702.
PMID: 39387423
13
Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?
Ucar SK, Mayr JA, Feichtinger RG, et al.
JIMD reports 2017; (35()):39-45 doi:10.1007/8904_2016_23.
PMID: 27928778
14
Mitochondrial DNA mutation "m.3243A>G"-Heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon).
Niedermayr K, Pölzl G, Scholl-Bürgi S, et al.
Congenital heart disease 2018; (13(5)):671-677 doi:10.1111/chd.12634.
PMID: 30133155
15
Clinical and molecular findings in a Moroccan family with Jervell and Lange-Nielsen syndrome: a case report.
Adadi N, Lahrouchi N, Bouhouch R, et al.
Journal of medical case reports 2017; (11(1)):88 doi:10.1186/s13256-017-1243-1.
PMID: 28364778
16
Audiometric Characteristics of a Dutch DFNA10 Family With Mid-Frequency Hearing Impairment.
van Beelen E, Oonk AM, Leijendeckers JM, et al.
Ear and hearing 2016; (37(1)):103-11 doi:10.1097/AUD.0000000000000217.
PMID: 26331839
17
Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients.
Cabanillas R, Diñeiro M, Cifuentes GA, et al.
BMC medical genomics 2018; (11(1)):58 doi:10.1186/s12920-018-0375-5.
PMID: 29986705
18
Identification of a novel truncation mutation of EYA4 in moderate degree hearing loss by targeted exome sequencing.
Choi HS, Kim AR, Kim SH, Choi BY
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2016; (273(5)):1123-9 doi:10.1007/s00405-015-3661-2.
PMID: 26015337

This page is for informational purposes only and does not constitute medical advice. It explains the biological and genetic links between hearing loss and dilated cardiomyopathy; ask your cardiology, hearing, and genetics teams to interpret your results and plan care.